New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Rocket Pharmaceuticals, Inc.
RCKT
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

1B

Biotechnology

Next Earning date - 24 Feb 2025

1B

Biotechnology

Next Earning date - 24 Feb 2025

9.86USD

Shape-0.02 ( -0.20%)
Market Closed (as of Feb 12, 21:00 EDT)
favorite-chart

Relative Strenght

6
favorite-chart

Volume Buzz

-18%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

69%

Quote Panel

Shape
Updated February 13, 2025
1W -4.64 % 1M -5.47 % 3M -33.47 % 1Y -65.88 %

Key Metrics

Shape
  • Market Cap

    1.05B


  • Shares Outstanding

    106.34M


  • Share in Float

    98.19M


  • Dividende

    0


  • Earning Date

    24 Feb 2025


  • Price Target

    9.86


  • Average Volume

    1.48M


  • Beta

    1.089


  • Range

    9.3301-31.47


  • Industry

    Biotechnology


  • Website

    https://rocketpharma.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

RCKT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$56M

ShapeNaN%

2025-Revenue

$2.22

Shape-212%

2025-EPS

0

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

32.00(224.54%)

Number of analyst

1

Last analyst upgrade/downgrade

Wedbush

initialise

Previous: Not converted

2024-12-30

Now: Outperform

Jefferies

initialise

Previous: Not converted

2024-12-18

Now: Buy

Goldman Sachs

initialise

Previous: Not converted

2024-04-02

Now: Neutral

Morgan Stanley

initialise

Previous: Not converted

2023-02-01

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.92
vs -0.69

Q1.23

arrow
arrow

N/A

-0.73
vs -0.67

Q2.23

arrow
arrow

N/A

-0.82
vs -0.83

Q3.23

arrow
arrow

N/A

-0.75
vs -0.87

Q4.23

arrow
arrow

N/A

-0.64
vs -0.92

Q1.24

arrow
arrow

N/A

-0.66
vs -0.73

Q2.24

arrow
arrow

N/A

-0.74
vs -0.82

Q3.24

arrow
arrow

N/A

-0.71
vs -0.75

Q4.24

arrow
arrow

N/A

-0.72
vs -0.64

Q1.25

arrow
arrow

N/A

-0.70
vs -0.66

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

10.3M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Q4.24

arrow
arrow

-100%

28.5K  vs 10.3M

Q1.25

arrow
arrow

NA

1.8M  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-13%

-0.13
vs -0.16

Q1.23

arrow
arrow

-12%

-0.12
vs -0.13

Q2.23

arrow
arrow

-16%

-0.16
vs -0.12

Q3.23

arrow
arrow

-11%

-0.11
vs -0.16

Q4.23

arrow
arrow

-12%

-0.12
vs -0.11

Q1.24

arrow
arrow

-14%

-0.14
vs -0.12

Q2.24

arrow
arrow

-18%

-0.18
vs -0.14

Q3.24

arrow
arrow

-20%

-0.20
vs -0.18

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

173

173
vs 168

3%

Q1.23

arrow
arrow

167

167
vs 173

-3%

Q2.23

arrow
arrow

167

167
vs 167

NA

Q3.23

arrow
arrow

188

188
vs 167

13%

Q4.23

arrow
arrow

209

209
vs 188

11%

Q1.24

arrow
arrow

199

199
vs 209

-5%

Q2.24

arrow
arrow

185

185
vs 199

-7%

Q3.24

arrow
arrow

198

198
vs 185

7%

Earnings Growth

Latest News